How much funding has Lepure Biotech raised?

Lepure Biotech has raised $54.0M in total funding, most recently a Series C round.

When was Lepure Biotech founded?

Lepure Biotech was founded in 2011.

Where is Lepure Biotech headquartered?

Lepure Biotech is headquartered in Shanghai, China.

What industry is Lepure Biotech in?

Lepure Biotech operates in Life Sciences.

How many employees does Lepure Biotech have?

Lepure Biotech has 501-1000 employees.

Lepure Biotech

Q: Who are Lepure Biotech's investors?

Lepure Biotech's investors include General Atlantic, Goldman Sachs, Novo Holdings A/S.

Empower Biopharma through High Quality

Shanghai, China · Founded 2011 · $54.0M raised

Life Sciences

Headquarters: Shanghai
Employees: 501–1000
Founded: 2011
Business Model: B2B

Website: lepurebiotech.com
Total Funding: $54.0M
Last Round: $54.0M Series CJan 2023
Rounds: 1

About

Founded in 2011, LePure Biotech specializes in single-use systems and consumables for the biopharmaceutical industry. The company offers reliable, high-quality bioprocessing solutions with vertically integrated manufacturing, from in-house film extrusion to final product assembly, ensuring quality, consistency, and control. With R&D and commercial operations across the U.S., South China, and Korea, LePure serves 3,000+ customers in 30+ countries and holds 200+ patents.

Summary

Lepure Biotech is a Life Sciences company based in Shanghai, China, founded in 2011. It has raised $54.0M in total across 1 round, most recently a $54.0M Series C round in Jan 2023. Investors include General Atlantic, Goldman Sachs and Novo Holdings A/S.